Universitätsklinikum Magdeburg A.ö.R. Institut für Humangenetik
170 capabilities
Accredited since June 2025
Verified May 2026
One of 3,188 in Germany
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Leipziger Straße 44
Magdeburg 39120 , Germany
Magdeburg 39120 , Germany
Accreditation
Active
DAkkS
D-ML-13264-04-00
Offers human genetic testing combining molecular diagnostics and cytogenetic analysis, including SNP array-based chromosome analysis and PCR sequencing for genetic variant detection in blood and tissue samples.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13264-04-00
Status
ActiveSince
20 June 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDF
Test Capabilities (170)
| Standard Reference | Description | Category |
|---|---|---|
| C9ORF72 | C9orf72 | Elemental Analysis |
| Cowden Syndrom | Cowden Syndrom | Elemental Analysis |
| Familiäre Hypercholesterinämie | Familiäre Hypercholesterinämie | Elemental Analysis |
| GLA; Morbus Fabry | GLA; Morbus Fabry | Elemental Analysis |
| (BWS) | Wiedemann-Syndrom (BWS): 11p15 | Molecular Diagnostics / PCR |
| (CCM2, KRIT1, PDCD10); SNV, CNV | (CCM2, KRIT1, PDCD10); SNV, CNV | Molecular Diagnostics / PCR |
| (CNV), Validierung von CNV | (CNV), Validierung von CNV | Molecular Diagnostics / PCR |
| (COL3A1); SNV, CNV | (COL3A1); SNV, CNV | Molecular Diagnostics / PCR |
| (DMD/BMD): DMD-Gen | (DMD/BMD): DMD-Gen | Molecular Diagnostics / PCR |
| (FXTAS) | Ataxie-Syndrom (FXTAS): FMR1 | Molecular Diagnostics / PCR |
| (MEN1): MEN1 | (MEN1): MEN1 | Molecular Diagnostics / PCR |
| (MEN2): RET | Neoplasie Typ 2 (MEN2) | Molecular Diagnostics / PCR |
| (PWS)WS/Angelman-Syndrom (AS) | (PWS)WS/Angelman-Syndrom (AS) | Molecular Diagnostics / PCR |
| (R3527H, R3558H), LPA, LDLR, PCSK9, LDLRAP1 | (R3527H, R3558H), LPA, LDLR, PCSK9, LDLRAP1 | Molecular Diagnostics / PCR |
| (SNV), Validierung von SNV | (SNV), Validierung von SNV | Molecular Diagnostics / PCR |
| 6q24.2, 7p12.2, 7q32.2, 11p15.5, 15q11.2, 19q13.43, 20q13.32 | 6q24.2, 7p12.2, 7q32.2, 11p15.5, 15q11.2, 19q13.43, 20q13.32 | Molecular Diagnostics / PCR |
| APC, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE,PTCH1, SMARCE1, SUFU, TP53, NF1, NF2, TSC1, TSC2 | APC, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE,PTCH1, SMARCE1, SUFU, TP53, NF1, NF2, TSC1, TSC2 | Molecular Diagnostics / PCR |
| Adrenogenitales Syndrom (AGS) | Adrenogenitales-Syndrom (AGS) | Molecular Diagnostics / PCR |
| Albinismus (AP3B1, BLOC1S3, BLOC1S6,TYRP1); SNV, CNV | Albinismus (AP3B1, BLOC1S3, BLOC1S6,TYRP1); SNV, CNV | Molecular Diagnostics / PCR |
| Alzheimer'sche Erkrankung (APOE, PSEN1, PSEN2); SNV, CNV | Alzheimer'sche Erkrankung (APOE, PSEN1, PSEN2); SNV, CNV | Molecular Diagnostics / PCR |
| Alzheimer'sche Erkrankung: APOE | Alzheimer'sche Erkrankung: APOE | Molecular Diagnostics / PCR |
| Amyotrophe Lateralsklerose (ALS): | Amyotrophe Lateralsklerose (ALS): | Molecular Diagnostics / PCR |
| Analyse (WES-Panel); SNV, CNV | Analyse (WES-Panel); SNV, CNV | Molecular Diagnostics / PCR |
| Ankerstörungen (GPAA1, PGAP1, PGAP2,PIGY); SNV, CNV | Ankerstörungen (GPAA1, PGAP1, PGAP2,PIGY); SNV, CNV | Molecular Diagnostics / PCR |
| Anämie, megaloblastär (ABCD4, AMN,UMPS); SNV, CNV | Anämie, megaloblastär (ABCD4, AMN,UMPS); SNV, CNV | Molecular Diagnostics / PCR |
| Aortenaneurysma (ABCC6, ACTA2, ACVR1,ZNF469); SNV, CNV | Aortenaneurysma (ABCC6, ACTA2, ACVR1,ZNF469); SNV, CNV | Molecular Diagnostics / PCR |
| Arteriopathie mit subkortikalen | Arteriopathie mit subkortikalen | Molecular Diagnostics / PCR |
| Arthrogrypose (ACTA1, ADCY6, ADGRG6,ZC4H2); SNV, CNV | Arthrogrypose (ACTA1, ADCY6, ADGRG6,ZC4H2); SNV, CNV | Molecular Diagnostics / PCR |
| Augenerkrankungen (ABCA4, ABCB6, ABHD12,ZNF469); SNV, CNV | Augenerkrankungen (ABCA4, ABCB6, ABHD12,ZNF469); SNV, CNV | Molecular Diagnostics / PCR |
| Autoinflammatorische Syndrome | Autoinflammatorische Syndrome | Molecular Diagnostics / PCR |
| Bindegewebserkrankungen inkl. | Bindegewebserkrankungen inkl. | Molecular Diagnostics / PCR |
| Blutbildungsdefekte (ABCB6, ABCB7, ABCD4,ZCCHC8); SNV, CNV | Blutbildungsdefekte (ABCB6, ABCB7, ABCD4,ZCCHC8); SNV, CNV | Molecular Diagnostics / PCR |
| Brust- und Eierstockkrebs | Familiärer Brust- und Eierstockkrebs | Molecular Diagnostics / PCR |
| CL3N58, CL3N59 (ZNF9-Gen) | CL3N58, CL3N59 (ZNF9-Gen) | Molecular Diagnostics / PCR |
| CNV | FMR1 [OMIM*309550], AFF2 [OMIM*300806]; SNV, CNV | Molecular Diagnostics / PCR |
| Cerebral cavernous malformations | Cerebral cavernous malformations | Molecular Diagnostics / PCR |
| Cerebrale Mikroangiopathien inkl. | Cerebrale Mikroangiopathien inkl. | Molecular Diagnostics / PCR |
| Cholestase (ABCB11, ABCB4, ABCC12,VPS33B); SNV, CNV | Cholestase (ABCB11, ABCB4, ABCC12,VPS33B); SNV, CNV | Molecular Diagnostics / PCR |
| Chorea Huntington | HD; Chorea Huntington | Molecular Diagnostics / PCR |
| Chromosomeninstabilitätssyndrome | Chromosomeninstabilitätssyndrome | Molecular Diagnostics / PCR |
| Cystische Fibrose (CF): CFTR | Cystische Fibrose (CF): CFTR | Molecular Diagnostics / PCR |
| Darmkrebs (CRC), unbestimmt | Darmkrebs (CRC), unbestimmt: | Molecular Diagnostics / PCR |
| Demenzerkrankungen (ADAR, ALS2, ANG,XPR1); SNV, CNV | Demenzerkrankungen (ADAR, ALS2, ANG,XPR1); SNV, CNV | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom, klassischer | Ehlers-Danlos-Syndrom, klassischer | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom, vaskulärer | Ehlers-Danlos-Syndrom, vaskulärer | Molecular Diagnostics / PCR |
| Entwicklungsstörungen - X-gebundene | Entwicklungsstörungen - X-gebundene | Molecular Diagnostics / PCR |
| Entwicklungsstörungen - syndromale | Entwicklungsstörungen - syndromale | Molecular Diagnostics / PCR |
| Erkrankungen | Neurodegenrative Erkrankungen | Molecular Diagnostics / PCR |
| Fiebersyndrome, periodisch (ADA2, APOA1,WDR1); SNV, CNV | Fiebersyndrome, periodisch (ADA2, APOA1,WDR1); SNV, CNV | Molecular Diagnostics / PCR |
| Fragiles X-Syndrom (FraX), Prämature | Fragiles X-Syndrom (FraX), Prämature | Molecular Diagnostics / PCR |
| GJB2, GJB6 | GJB2, GJB6 | Molecular Diagnostics / PCR |
| Gefäßmalformationen, regionaler | Gefäßmalformationen, regionaler | Molecular Diagnostics / PCR |
| Genetisch bedingte Adipositas | Genetisch bedingte Adipositas | Molecular Diagnostics / PCR |
| Gliedergürtel-Muskeldystrophien | Gliedergürtelmuskeldystrophien | Molecular Diagnostics / PCR |
| Glut1-Defizienz-Syndrom | Glut1-Defizienz-Syndrom | Molecular Diagnostics / PCR |
| HAMP; erbl. Hämochromatose | HAMP; erbl. Hämochromatose | Molecular Diagnostics / PCR |
| Hereditäre Neuropathie mit Neigung | Hereditäre Neuropathie mit Neigung | Molecular Diagnostics / PCR |
| Hereditäre Sensomotorische Neuropathien | Hereditäre Sensomotorische Neuropathien | Molecular Diagnostics / PCR |
| Hereditäre spastische Paraparesen | Hereditäre spastische Paraparesen | Molecular Diagnostics / PCR |
| Herzfehler, genetisch (AARS2, ABCC9,VCP); SNV, CNV | Herzfehler, genetisch (AARS2, ABCC9,VCP); SNV, CNV | Molecular Diagnostics / PCR |
| Hypogonadotroper Hypogonadismus | Hypogonadotroper Hypogonadismus | Molecular Diagnostics / PCR |
| Hämophilie A (F8); SNV, CNV | Hämophilie A (F8); SNV, CNV | Molecular Diagnostics / PCR |
| Joubert-Syndrom (AHI1, ARL13B, ARL3,ZNF423); SNV, CNV | Joubert-Syndrom (AHI1, ARL13B, ARL3,ZNF423); SNV, CNV | Molecular Diagnostics / PCR |
| Kardiomyopathie (AARS2, ABCC9, ACAD9,TGFB3); SNV, CNV | Kardiomyopathie (AARS2, ABCC9, ACAD9,TGFB3); SNV, CNV | Molecular Diagnostics / PCR |
| Karzinom (HNPCC) (EPCAM, MLH1, MSH2,…, PMS2); SNV, CNV | Karzinom (HNPCC) (EPCAM, MLH1, MSH2,…, PMS2); SNV, CNV | Molecular Diagnostics / PCR |
| Karzinom (HNPCC) (EPCAM, MLH1, MSH3, MSH6, PMS2) | Karzinom (HNPCC) (EPCAM, MLH1, MSH3, MSH6, PMS2) | Molecular Diagnostics / PCR |
| Klippel-Feil-Syndrom (DLL3, GDF3, GDF6,ZIC3); SNV, CNV | Klippel-Feil-Syndrom (DLL3, GDF3, GDF6,ZIC3); SNV, CNV | Molecular Diagnostics / PCR |
| Leukodystrophien, Leukoenzephalopathien | Leukodystrophien, Leukoenzephalopathien | Molecular Diagnostics / PCR |
| Leukämie (JMML) (GNAS, LZTR1, NF1,SPRED1); SNV, CNV | Leukämie (JMML) (GNAS, LZTR1, NF1,SPRED1); SNV, CNV | Molecular Diagnostics / PCR |
| Li Fraumeni Syndrom | Li-Fraumeni-Syndrom | Molecular Diagnostics / PCR |
| Lipodystrophie (AGPAT2, AKT2, BANF1,ZMPSTE24); SNV, CNV | Lipodystrophie (AGPAT2, AKT2, BANF1,ZMPSTE24); SNV, CNV | Molecular Diagnostics / PCR |
| Lymphatische Malformationen | Lymphatische Malformationen | Molecular Diagnostics / PCR |
| Lynch-Syndrom / Hereditäres | Lynch-Syndrom / Hereditäres | Molecular Diagnostics / PCR |
| MD102 (DMPK-Gen) | MD102 (DMPK-Gen) | Molecular Diagnostics / PCR |
| Magen-Ca, unbestimmt (CDH1, EPCAM,PMS2); SNV, CNV | Magen-Ca, unbestimmt (CDH1, EPCAM,PMS2); SNV, CNV | Molecular Diagnostics / PCR |
| Magen-Karzinom, diffuses: CDH1 | Magen-Karzinom, diffuses: CDH1 | Molecular Diagnostics / PCR |
| Makrozephalie, Großwuchs (AKT1, AKT3,UPF3B); SNV, CNV | Makrozephalie, Großwuchs (AKT1, AKT3,UPF3B); SNV, CNV | Molecular Diagnostics / PCR |
| Marfan-Syndrom und Typ 1 | Marfan-Syndrom und Typ 1 | Molecular Diagnostics / PCR |
| MeCP2; Rett-Syndrom | MeCP2; Rett-Syndrom | Molecular Diagnostics / PCR |
| Medulloblastom (APC, BRCA2, CTNNB1,TP53); SNV, CNV | Medulloblastom (APC, BRCA2, CTNNB1,TP53); SNV, CNV | Molecular Diagnostics / PCR |
| Migrationsstörungen (ACTB, ACTG1, ADGRG1,WDR81); SNV, CNV | Migrationsstörungen (ACTB, ACTG1, ADGRG1,WDR81); SNV, CNV | Molecular Diagnostics / PCR |
| Mikrozephalie (AMPD2, ANKLE2, ASNS,ZNF335); SNV, CNV | Mikrozephalie (AMPD2, ANKLE2, ASNS,ZNF335); SNV, CNV | Molecular Diagnostics / PCR |
| Mitochondropathien (AARS2, ABCC8, ABCD1,ZNHIT3); SNV, CNV | Mitochondropathien (AARS2, ABCC8, ABCD1,ZNHIT3); SNV, CNV | Molecular Diagnostics / PCR |
| Mukopolysaccharidose (ABCC8, ADAMTSL2,TPP1); SNV, CNV | Mukopolysaccharidose (ABCC8, ADAMTSL2,TPP1); SNV, CNV | Molecular Diagnostics / PCR |
| Mukoviszidose | Mukoviszidose | Molecular Diagnostics / PCR |
| Multi-Locus-Imprinting Defekt (MLID): | Multi-Locus-Imprinting Defekt (MLID): | Molecular Diagnostics / PCR |
| Multiple Endokrine Neoplasie Typ | Multiple endokrine Neoplasie Typ | Molecular Diagnostics / PCR |
| Muskeldystrophie Duchenne/Becker | Muskeldystrophie Duchenne/Becker | Molecular Diagnostics / PCR |
| Muskeldystrophie, kongenitale | Muskeldystrophie, kongenitale | Molecular Diagnostics / PCR |
| Myotone Dystrophie Typ 1 (DM1): | Myotone Dystrophie Typ 1 (DM1): | Molecular Diagnostics / PCR |
| Nephrotisches Syndrom (ACE, COQ8B,WT1); SNV, CNV | Nephrotisches Syndrom (ACE, COQ8B,WT1); SNV, CNV | Molecular Diagnostics / PCR |
| Neuromuskuläre Erkrankungen | Neuromuskuläre Erkrankungen | Molecular Diagnostics / PCR |
| Neuropathien, Motoneuropathien | Neuropathien, Motoneuropathien | Molecular Diagnostics / PCR |
| Nicht-Polypöses Kolorektales | Nicht-Polypöses Kolorektales | Molecular Diagnostics / PCR |
| Optikusatrophie (ACO2, AFG3L2, C12orf65,YME1L1); SNV, CNV | Optikusatrophie (ACO2, AFG3L2, C12orf65,YME1L1); SNV, CNV | Molecular Diagnostics / PCR |
| Osteogenesis imperfecta (OI) (ALPL, ATP6V0A2,WNT1); SNV, CNV | Osteogenesis imperfecta (OI) (ALPL, ATP6V0A2,WNT1); SNV, CNV | Molecular Diagnostics / PCR |
| PROC | PROC | Molecular Diagnostics / PCR |
| PROS1 | PROS1 | Molecular Diagnostics / PCR |
| PRRT2 | PRRT2 | Molecular Diagnostics / PCR |
| Pankreas-Ca assoziierte Syndrome | Pankreas-Ca assoziierte Syndrome | Molecular Diagnostics / PCR |
| Pankreatitis | Pankreatitis | Molecular Diagnostics / PCR |
| Periventrikuläre noduläre Heterotopie | Periventrikuläre noduläre Heterotopie | Molecular Diagnostics / PCR |
| Phäochromozytom, Paragangliom | Phäochromozytom, Paragangliom | Molecular Diagnostics / PCR |
| Prostata-Ca, unbestimmt (ATM, BRCA2,…, PMS2); SNV, CNV | Prostata-Ca, unbestimmt (ATM, BRCA2,…, PMS2); SNV, CNV | Molecular Diagnostics / PCR |
| Proximale Myotone Myopathie | Proximale Myotone Myopathie | Molecular Diagnostics / PCR |
| Prämature Ovarialinsuffizienz (POI) | Prämature Ovarialinsuffizienz (POI) | Molecular Diagnostics / PCR |
| Rasopathien, fetales RASopathie-Syndrom | Rasopathien, fetales RASopathie-Syndrom | Molecular Diagnostics / PCR |
| Rhythmusstörungen (ABCC9, AKAP9, ANK2,TTN); SNV, CNV | Rhythmusstörungen (ABCC9, AKAP9, ANK2,TTN); SNV, CNV | Molecular Diagnostics / PCR |
| SNRPN-Region 15q11-13 UPD15 | SNRPN-Region 15q11-13 UPD15 | Molecular Diagnostics / PCR |
| Schwerhörigkeit, nicht syndromal | Schwerhörigkeit, nicht-syndromal: | Molecular Diagnostics / PCR |
| Sensorineutrale Schwerhörigkeit | Sensorineutrale Schwerhörigkeit | Molecular Diagnostics / PCR |
| Serratiertes Polyposis-Syndrom | Serratiertes Polyposis-Syndrom | Molecular Diagnostics / PCR |
| Small fiber neuropathy (SFN) (ATL1, CAV3,GBA); SNV, CNV | Small fiber neuropathy (SFN) (ATL1, CAV3,GBA); SNV, CNV | Molecular Diagnostics / PCR |
| Spinale Muskelatrophie (SMA) | Spinale Muskelatrophie (SMA): | Molecular Diagnostics / PCR |
| Spinalparalysen und Differenzialdiagnosen | Spinalparalysen und Differenzialdiagnosen | Molecular Diagnostics / PCR |
| Spinobulbäre Muskelatrophie (SBMA): | Spinobulbäre Muskelatrophie (SBMA): | Molecular Diagnostics / PCR |
| Spinozerebelläre Ataxie (SCA1, SCA6, SCA7, SCA11): ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, TBP | Spinozerebelläre Ataxie (SCA1, SCA6, SCA7, SCA11): ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, TBP | Molecular Diagnostics / PCR |
| Stoffwechselstörungen inkl. | Stoffwechselstörungen inkl. | Molecular Diagnostics / PCR |
| Syndrom und Rett-like-Syndrom | Syndrom und Rett-like-Syndrom | Molecular Diagnostics / PCR |
| Syndrom, MCAP-Syndrom (AKT1, ELMO2,VHL); SNV, CNV | Syndrom, MCAP-Syndrom (AKT1, ELMO2,VHL); SNV, CNV | Molecular Diagnostics / PCR |
| Syndrom, juvenile myelomonozytäre | Syndrom, juvenile myelomonozytäre | Molecular Diagnostics / PCR |
| Thrombophilie Proteil-S-Mangel | Thrombophilie Proteil-S-Mangel | Molecular Diagnostics / PCR |
| Thrombophilie Protein-C-Mangel | Thrombophilie Protein-C-Mangel | Molecular Diagnostics / PCR |
| Tooth Neuropathie Typ 1A (CMT1A, HMSN1A): 17p12 | Tooth Neuropathie Typ 1A (CMT1A, HMSN1A): 17p12 | Molecular Diagnostics / PCR |
| Tuberöse Sklerose Typ 1 und Typ | Tuberöse Sklerose Typ 1 und Typ | Molecular Diagnostics / PCR |
| Tumorprädisposition (ABRAXAS1, AKT1,XRCC2); SNV, CNV | Tumorprädisposition (ABRAXAS1, AKT1,XRCC2); SNV, CNV | Molecular Diagnostics / PCR |
| Tumorprädisposition (AKT1, APC, ATM,TP53); SNV, CNV | Tumorprädisposition (AKT1, APC, ATM,TP53); SNV, CNV | Molecular Diagnostics / PCR |
| UPD14: 14q32 | UPD14: 14q32 | Molecular Diagnostics / PCR |
| UPD6: 6q24 | UPD6: 6q24 | Molecular Diagnostics / PCR |
| UPD7: 7p12, 7q32 | UPD7: 7p12, 7q32 | Molecular Diagnostics / PCR |
| Untersuchung auf familiäre Varianten | Untersuchung auf familiäre Varianten | Molecular Diagnostics / PCR |
| Wilms-Tumor, Denys-Drash-Syndrom: | Wilms-Tumor, Denys-Drash-Syndrom: | Molecular Diagnostics / PCR |
| X-Inaktivierung (XCI): FMR1, AR, | X-Inaktivierung (XCI): FMR1, AR, | Molecular Diagnostics / PCR |
| Ziliopathien (ACVR2B, AHI1, ALMS1,ZNF423); SNV, CNV | Ziliopathien (ACVR2B, AHI1, ALMS1,ZNF423); SNV, CNV | Molecular Diagnostics / PCR |
| assoziierte Polyposis (MAP), juvenile | assoziierte Polyposis (MAP), juvenile | Molecular Diagnostics / PCR |
| hereditäre Lymphödeme, inkl. pränatale | hereditäre Lymphödeme, inkl. pränatale | Molecular Diagnostics / PCR |
| isolierte, Skaphokephalie, isolierte: | isolierte, Skaphokephalie, isolierte: | Molecular Diagnostics / PCR |
| kongenitaler Hyperinsulinismus | kongenitaler Hyperinsulinismus | Molecular Diagnostics / PCR |
| spastische Paraplegien (SPG), spastische | spastische Paraplegien (SPG), spastische | Molecular Diagnostics / PCR |
| syndromal (ADGRV1, AIFM1, ALMS1,WHRN); SNV, CNV | syndromal (ADGRV1, AIFM1, ALMS1,WHRN); SNV, CNV | Molecular Diagnostics / PCR |
| thorakale Aortenerweiterung (ACTA2, COL3A1, FBN1,TGFBR2); SNV, CNV | thorakale Aortenerweiterung (ACTA2, COL3A1, FBN1,TGFBR2); SNV, CNV | Molecular Diagnostics / PCR |
| und Differentialdiagnosen (ABHD5, ACADM, ACADS,YARS2); SNV, CNV | und Differentialdiagnosen (ABHD5, ACADM, ACADS,YARS2); SNV, CNV | Molecular Diagnostics / PCR |
| young (MODY) (ABCC8, AKT2, APPL1,TRMT10A); SNV, CNV | young (MODY) (ABCC8, AKT2, APPL1,TRMT10A); SNV, CNV | Molecular Diagnostics / PCR |
| zerebrale autosomal-dominante | zerebrale autosomal-dominante | Molecular Diagnostics / PCR |
| (Exon 7 und 8), SMN2 (Exon 7 und | (Exon 7 und 8), SMN2 (Exon 7 und | Other |
| 2143delT, 2184delA, 3272-26A>G, G85E, 621+1G>T, 3659delC, R334W, 1677delTA, 1078delT, E92*, 3905insT, E60*, I336K, 2184insA, A455E, Y1092*) | 2143delT, 2184delA, 3272-26A>G, G85E, 621+1G>T, 3659delC, R334W, 1677delTA, 1078delT, E92*, 3905insT, E60*, I336K, 2184insA, A455E, Y1092*) | Other |
| AARS1, ABCA1,YARS1); SNV, CNV | AARS1, ABCA1,YARS1); SNV, CNV | Other |
| AARS1, ABCC9,ZFHX2); SNV, CNV | AARS1, ABCC9,ZFHX2); SNV, CNV | Other |
| AARS2, ABCB7,ZNHIT3); SNV, CNV | AARS2, ABCB7,ZNHIT3); SNV, CNV | Other |
| ACVR1, ADSS1,YARS2); SNV, CNV | ACVR1, ADSS1,YARS2); SNV, CNV | Other |
| ADRB2, ADRB3,WDPCP); SNV, CNV | ADRB2, ADRB3,WDPCP); SNV, CNV | Other |
| ARX, ASXL1,ZEB2); SNV, CNV | ARX, ASXL1,ZEB2); SNV, CNV | Other |
| ATM, ATR,ZBTB24); SNV, CNV | ATM, ATR,ZBTB24); SNV, CNV | Other |
| ATM, BRCA1,…,TP53); SNV, CNV | ATM, BRCA1,…,TP53); SNV, CNV | Other |
| AXIN2,STK11); SNV, CNV | AXIN2,STK11); SNV, CNV | Other |
| Allel), APP (Exon 16 und 17) | Allel), APP (Exon 16 und 17) | Other |
| BAP1, CDC73,VHL); SNV, CNV | BAP1, CDC73,VHL); SNV, CNV | Other |
| BMPR1A, MUTYH, NTHL1, POLD1, SMAD4, STK11) | BMPR1A, MUTYH, NTHL1, POLD1, SMAD4, STK11) | Other |
| CARD8, CD70,WDR1); SNV, CNV | CARD8, CD70,WDR1); SNV, CNV | Other |
| CHCHD10, FUS,…, VCP); SNV, CNV | CHCHD10, FUS,…, VCP); SNV, CNV | Other |
| CHEK2, PALB2, PTEN, RAD51C, STK11, TP53) | CHEK2, PALB2, PTEN, RAD51C, STK11, TP53) | Other |
| Epilepsie (AARS1, ABAT, ACY1,…, SNV, CNV | Epilepsie (AARS1, ABAT, ACY1,…, SNV, CNV | Other |
| Fibrillinopathien (FBN1, TGFBR1, SNV, CNV | Fibrillinopathien (FBN1, TGFBR1, SNV, CNV | Other |
| Hauptmutationen (N1303K, F508del, R553*, G542*, G551D, R347P, 3849+10kb | Hauptmutationen (N1303K, F508del, R553*, G542*, G551D, R347P, 3849+10kb | Other |
| Hereditäres | SERPING1, F12 (Hereditäres | Other |
| Kraniosynostosen (ALPL, ALX1, SNV, CNV | Kraniosynostosen (ALPL, ALX1, SNV, CNV | Other |
| Lymphödeme (AKT1, BRAF, CBL,…, SNV, CNV | Lymphödeme (AKT1, BRAF, CBL,…, SNV, CNV | Other |
| Mixed Polyposis-Syndrom (HMPS)) | Mixed Polyposis-Syndrom (HMPS)) | Other |
| Polyposis-Syndrome (Familiäre | Polyposis-Syndrome (Familiäre | Other |
| Syndrom (MPPH) (AKT3, CCND2, SNV, CNV | Syndrom (MPPH) (AKT3, CCND2, SNV, CNV | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.